Live feed19:05:23·71dINSIDERFilingvia QuantisnowChief Scientific Officer Bredt David sold $246,655 worth of shares (8,500 units at $29.02) and exercised 6,000 shares at a strike of $1.80, decreasing direct ownership by 0.63% to 393,075 units (SEC Form 4)ByQuantisnow·Wall Street's wire, on your screen.RAPP· Rapport Therapeutics Inc.Health CareOriginal source
